Review




Structured Review

DILIsym Services Inc dilisym pbpk submodel
Parameters Used in the <t> DILIsym PBPK Submodel </t> for Riluzole
Dilisym Pbpk Submodel, supplied by DILIsym Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+submodels/pmc07253195-58-4-4?v=DILIsym+Services+Inc
Average 90 stars, based on 1 article reviews
dilisym pbpk submodel - by Bioz Stars, 2026-07
90/100 stars

Images

1) Product Images from "Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym"

Article Title: Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym

Journal: Toxicological Sciences

doi: 10.1093/toxsci/kfaa019

Parameters Used in the  DILIsym PBPK Submodel  for Riluzole
Figure Legend Snippet: Parameters Used in the DILIsym PBPK Submodel for Riluzole

Techniques Used: Clinical Proteomics, Protein Binding, Molecular Weight



Similar Products

90
DILIsym Services Inc dilisym pbpk submodel
Parameters Used in the <t> DILIsym PBPK Submodel </t> for Riluzole
Dilisym Pbpk Submodel, supplied by DILIsym Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+submodels/pmc07253195-58-4-4?v=DILIsym+Services+Inc
Average 90 stars, based on 1 article reviews
dilisym pbpk submodel - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
DILIsym Services Inc pbpk submodel
Diagrams of hepatobiliary disposition of bilirubin ( a ) and the bilirubin <t>submodel</t> structure within DILIsym ( b ). CB, conjugated bilirubin; DJS, Dubin‐Johnson Syndrome; GS, Gilbert's Syndrome; HC, hepatocytes; MRP, multidrug resistance‐associated protein; OATP, organic anion transporting polypeptide; RBC, red blood cell; RS, Rotor Syndrome; UB, unconjugated bilirubin; UGT, UDP glucuronosyltransferase.
Pbpk Submodel, supplied by DILIsym Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+submodels/pmc05367379-162-10-13?v=DILIsym+Services+Inc
Average 90 stars, based on 1 article reviews
pbpk submodel - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
DILIsym Services Inc pbpk submodels
List of parameters varied in the SimPops™ and results of multiple‐regression analysis in SimPops™ administered tolcapone (200 mg t.i.d. for 1 week)
Pbpk Submodels, supplied by DILIsym Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+submodels/pmc04728295-150-4-15?v=DILIsym+Services+Inc
Average 90 stars, based on 1 article reviews
pbpk submodels - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
DILIsym Services Inc physiologically-based pharmacokinetic (pbpk) submodel
List of parameters varied in the SimPops™ and results of multiple‐regression analysis in SimPops™ administered tolcapone (200 mg t.i.d. for 1 week)
Physiologically Based Pharmacokinetic (Pbpk) Submodel, supplied by DILIsym Services Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+submodels/10__1002_slash_hep__28203-65-12-7?v=DILIsym+Services+Inc
Average 90 stars, based on 1 article reviews
physiologically-based pharmacokinetic (pbpk) submodel - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Parameters Used in the  DILIsym PBPK Submodel  for Riluzole

Journal: Toxicological Sciences

Article Title: Assessing Effects of BHV-0223 40 mg Zydis Sublingual Formulation and Riluzole 50 mg Oral Tablet on Liver Function Test Parameters Utilizing DILIsym

doi: 10.1093/toxsci/kfaa019

Figure Lengend Snippet: Parameters Used in the DILIsym PBPK Submodel for Riluzole

Article Snippet: The structure of the DILIsym PBPK submodel has been discussed in detail elsewhere ( Howell et al. , 2012 ; Woodhead et al. , 2012 , ).

Techniques: Clinical Proteomics, Protein Binding, Molecular Weight

Diagrams of hepatobiliary disposition of bilirubin ( a ) and the bilirubin submodel structure within DILIsym ( b ). CB, conjugated bilirubin; DJS, Dubin‐Johnson Syndrome; GS, Gilbert's Syndrome; HC, hepatocytes; MRP, multidrug resistance‐associated protein; OATP, organic anion transporting polypeptide; RBC, red blood cell; RS, Rotor Syndrome; UB, unconjugated bilirubin; UGT, UDP glucuronosyltransferase.

Journal: Clinical Pharmacology and Therapeutics

Article Title: Systems pharmacology modeling of drug‐induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters

doi: 10.1002/cpt.619

Figure Lengend Snippet: Diagrams of hepatobiliary disposition of bilirubin ( a ) and the bilirubin submodel structure within DILIsym ( b ). CB, conjugated bilirubin; DJS, Dubin‐Johnson Syndrome; GS, Gilbert's Syndrome; HC, hepatocytes; MRP, multidrug resistance‐associated protein; OATP, organic anion transporting polypeptide; RBC, red blood cell; RS, Rotor Syndrome; UB, unconjugated bilirubin; UGT, UDP glucuronosyltransferase.

Article Snippet: Physiological parameters for tissue volumes and blood flows in the PBPK submodel of DILIsym were published elsewhere.

Techniques:

List of parameters varied in the SimPops™ and results of multiple‐regression analysis in SimPops™ administered tolcapone (200 mg t.i.d. for 1 week)

Journal: CPT: Pharmacometrics & Systems Pharmacology

Article Title: Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym ® , a Mechanistic Model of Drug‐Induced Liver Injury

doi: 10.1002/psp4.12053

Figure Lengend Snippet: List of parameters varied in the SimPops™ and results of multiple‐regression analysis in SimPops™ administered tolcapone (200 mg t.i.d. for 1 week)

Article Snippet: Via the use of PBPK submodels developed to describe the disposition of tolcapone and entacapone, DILIsym ® predicted lower hepatic exposure for entacapone than for tolcapone for clinically relevant dosing regimens of each compound.

Techniques: